NUVARING Adverse Event: Pulmonary embolism
NUVARING Adverse Event: Pulmonary embolism is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: NUVARING; Product category: Drug; Primary reaction: Pulmonary embolism.
| Primary drug | NUVARING |
|---|---|
| Product category | Drug |
| Primary reaction | Pulmonary embolism |
| All reactions | Pulmonary embolism; Poor venous access; Troponin increased; Cardiac ventricular disorder; Brain natriuretic peptide increased |
| Seriousness | Serious |
| Patient outcome | Unknown |
| Patient sex | Female |
| All drugs reported | NUVARING; NUVARING |
| Reporter country | US |
| Reporter type | 2 |
| Report date | 20140312 |
| Report ID | 10007177 |
$299/mo
Try FDATracker →